Early administration of <scp>COVID</scp>‐19 convalescent plasma with high titer antibody content by live viral neutralization assay is associated with modest clinical efficacyArtur Belov, Peter Marks, Anne F. Eder et al.|American Journal of Hematology|2022Cited by 21
FDA Review of Investigational Use of COVID-19 Convalescent PlasmaSalim El Haddad, Nicole Verdun, Laurence Landow et al.|Unknown|2020Cited by 6